Crosslinks Leverages TIBCO Spotfire Enterprise Analytics to Power Bioinformatics Research Analysis Across Europe

TIBCO Software Inc. (NASDAQ: TIBX) today announced that Crosslinks, a provider of services, solutions and technology in the field of new advanced visual informatics software, has selected the TIBCO Spotfire® enterprise analytics platform to power research analysis advancements across Europe in the field of bioinformatics. The new partnership underpins Crosslinks' mission to foster the scientific exchange of ideas, guides and use cases between members of the bioinformatics world throughout the European continent and address the industry's move towards a more diagnostic approach. The TIBCO Spotfire enterprise analytics platform will provide a fundamental tool for the sharing of research in areas such as genomics and proteomics analysis between academic organisations through streamlined and easy-to-use analytics workflows.

Founded in 2006, Crosslinks is a spin-off from the department of Bioinformatics at the Erasmus University Medical Center (Erasmus MC) in Rotterdam, the Netherlands. Its services, solutions and technologies are designed to deal with large data sets for life sciences companies and biomedical research. Crosslinks has rapidly established itself as a leading partner in the field of molecular imaging and molecular diagnostics due to its combination of cutting-edge information and communications technologies (ICT) and in-depth knowledge of life sciences and medical research.

"We have known Spotfire for several years, having used the Spotfire® enterprise analytics platform from an academic perspective when we were part of Erasmus MC," explained Ronald Nanninga, CEO and co-founder of Crosslinks. "When Crosslinks was launched, our aim was always to provide the Spotfire enterprise analytics platform to the academic world. Under the terms of the new license agreement signed with TIBCO at the start of the year, we have started to provide licensing agreements to academic researchers in the Netherlands and the rest of Europe who are active in the field of life sciences -- especially genomics and proteomics."

The TIBCO Spotfire enterprise analytics platform will allow academic users within the field of bioinformatics to analyze a wide range of data in a very flexible manner, providing summary information and visualizations at great speed. Microarray experiments or, more generally, results from genomic experiments can be integrated with non-numerical data to facilitate target identification or patient stratification.

Under the terms of the new license agreement, Crosslinks will also be instrumental in the implementation of the TIBCO Spotfire enterprise analytics platform, working closely with scientists to provide training to users of the solution.

"This new licensing agreement with Crosslinks further demonstrates TIBCO Spotfire's long-established reputation within the life sciences industry," said Christian Marcazzo, vice president of European Life Sciences Sales, TIBCO Spotfire. "By creating a framework by which scientists and researchers can easily collaborate and communicate their methodologies, those academic institutions working with Crosslinks will greatly benefit from the TIBCO Spotfire enterprise analytics platform to speed the revelation of genomics insights."

About Crosslinks

Crosslinks BV is a high-tech bioinformatics company focused on delivering services, solutions and technology. Advanced visual analysis software designed to deal with large data sets (i.e. from genomics and proteomics experiments) is used to support public and private R&D in biomedical research and diagnostics. Crosslinks' current projects include producing robust software as a service diagnostic ICT pipeline to support microarray-based diagnosis (i.e. Acute Myeloid Leukaemia (AML) and the V-Scope visualization project. The diagnostic ICT pipeline is designed to be FDA compliant and can be adapted to the application of different diagnostic products in the near future. The V-Scope project provides 3-D medical image rendering and virtual reality visualization solutions to enable researchers and clinicians to develop new understanding of anatomy and perform complex multidisciplinary molecular imaging studies to explore on- or off-target effects. Fore more information, visit http://crosslinks-it.com and http://v-scope.nl.